Oarsman Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
34,779
+634
+2% +$51.1K 0.29% 57
2026
Q1
$2.96M Buy
34,145
+62
+0.2% +$5.94K 0.37% 47
2025
Q4
$3.27M Buy
34,083
+546
+2% +$53K 0.42% 39
2025
Q3
$3.19M Buy
33,537
+711
+2% +$65.4K 0.45% 40
2025
Q2
$2.86M Sell
32,826
-507
-2% -$43K 0.45% 40
2025
Q1
$3M Buy
33,333
+2,933
+10% +$262K 0.54% 33
2024
Q4
$2.43M Buy
30,400
+2,353
+8% +$204K 0.42% 44
2024
Q3
$2.53M Buy
28,047
+3,984
+17% +$335K 0.46% 43
2024
Q2
$1.89M Buy
24,063
+7,601
+46% +$623K 0.41% 53
2024
Q1
$1.43M Sell
16,462
-235
-1% -$20.1K 0.34% 68
2023
Q4
$1.38M Sell
16,697
-334
-2% -$25.5K 0.37% 64
2023
Q3
$1.33M Buy
17,031
+1,112
+7% +$93.1K 0.56% 47
2023
Q2
$1.4M Buy
15,919
+3,737
+31% +$322K 0.61% 47
2023
Q1
$982K Buy
12,182
+573
+5% +$46.7K 0.46% 63
2022
Q4
$902K Buy
11,609
+176
+2% +$14.3K 0.46% 66
2022
Q3
$923K Sell
11,433
-1,890
-14% -$170K 0.49% 58
2022
Q2
$1.2M Sell
13,323
-1,000
-7% -$101K 0.59% 50
2022
Q1
$1.59M Buy
14,323
+1,639
+13% +$173K 0.62% 51
2021
Q4
$1.31M Sell
12,684
-770
-6% -$89.2K 0.52% 62
2021
Q3
$1.69M Buy
13,454
+155
+1% +$20.1K 0.68% 45
2021
Q2
$1.65M Sell
13,299
-110
-0.8% -$13.8K 0.66% 50
2021
Q1
$1.58M Sell
13,409
-2,183
-14% -$256K 0.69% 48
2020
Q4
$1.83M Sell
15,592
-998
-6% -$110K 0.71% 39
2020
Q3
$1.72M Sell
16,590
-485
-3% -$48.7K 0.78% 40
2020
Q2
$1.57M Buy
17,075
+3,193
+23% +$306K 0.77% 39
2020
Q1
$1.25M Sell
13,882
-9,057
-39% -$964K 1.16% 29
2019
Q4
$2.6M Sell
22,939
-695
-3% -$76.3K 1.19% 23
2019
Q3
$2.57M Sell
23,634
-730
-3% -$76.2K 1.22% 23
2019
Q2
$2.37M Buy
24,364
+462
+2% +$42.2K 1.08% 29
2019
Q1
$2.18M Buy
23,902
+45
+0.2% +$4.03K 1.03% 33
2018
Q4
$2.17M Buy
23,857
+145
+0.6% +$13.6K 1.11% 25
2018
Q3
$2.33M Buy
23,712
+120
+0.5% +$11.1K 0.94% 34
2018
Q2
$2.02M Buy
23,592
+1,109
+5% +$92.6K 0.92% 36
2018
Q1
$1.8M Buy
22,483
+1,248
+6% +$103K 0.82% 40
2017
Q4
$1.72M Buy
21,235
+2,456
+13% +$197K 0.74% 43
2017
Q3
$1.46M Buy
18,779
+3,436
+22% +$285K 0.62% 53
2017
Q2
$1.36M Buy
15,343
+130
+0.9% +$11K 0.62% 55
2017
Q1
$1.23M Buy
15,213
+3,214
+27% +$251K 0.57% 60
2016
Q4
$855K Sell
11,999
-3,913
-25% -$307K 0.55% 63
2016
Q3
$1.38M Sell
15,912
-143
-0.9% -$12.5K 0.7% 45
2016
Q2
$1.39M Sell
16,055
-4,078
-20% -$330K 0.72% 47
2016
Q1
$1.51M Sell
20,133
-2,419
-11% -$182K 0.8% 45
2015
Q4
$1.74M Sell
22,552
-2,943
-12% -$222K 0.97% 33
2015
Q3
$1.71M Sell
25,495
-37
-0.1% -$2.73K 1.01% 28
2015
Q2
$1.89M Sell
25,532
-123
-0.5% -$9.4K 1.29% 16
2015
Q1
$2M Sell
25,655
-105
-0.4% -$7.96K 1.38% 14
2014
Q4
$1.86M Sell
25,760
-183
-0.7% -$12.7K 1.34% 18
2014
Q3
$1.61M Sell
25,943
-893
-3% -$56.8K 1.18% 20
2014
Q2
$1.71M Buy
26,836
+365
+1% +$22.2K 1.24% 18
2014
Q1
$1.63M Sell
26,471
-195
-0.7% -$11.4K 1.26% 15
2013
Q4
$1.53M Sell
26,666
-140
-0.5% -$7.94K 1.23% 19
2013
Q3
$1.43M Buy
26,806
+1,090
+4% +$58.7K 1.25% 17
2013
Q2
$1.32M Buy
+25,716
New +$1.27M 1.25% 21

Other funds holding MDT

Oarsman Capital's MDT Position: Q2 2026 in Review

Oarsman Capital increased its Medtronic (MDT) stake by 1.9% in Q2 2026, buying an estimated $51.1K and bringing the position to 34,779 shares worth $2.72M. The position accounts for 0.29% of the portfolio, ranked #57.

Oarsman Capital first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.27M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oarsman Capital held 34,779 shares of Medtronic worth $2.72M as of Q2 2026.
  • Oarsman Capital bought 634 Medtronic shares in Q2 2026, an estimated $51.1K.
  • Medtronic made up 0.29% of Oarsman Capital's portfolio in Q2 2026, its #57 holding.
  • Oarsman Capital first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Oarsman Capital's Medtronic position peaked at $3.27M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.